共查询到20条相似文献,搜索用时 0 毫秒
1.
2.
3.
Herzlinger R 《Medical economics》1997,74(19):96-8, 101, 105
4.
5.
F E Young 《Nursing economic$》1989,7(5):242-248
The Food and Drug Administration (FDA) has recently been the target of congressional investigations and has seen recent changes in its approval procedures. In this interview, FDA Commissioner Frank Young responds to harsh congressional criticisms and details the FDA approval process. 相似文献
6.
James BC 《Medical economics》1995,72(18):112-4, 126-8, 130
7.
J J Clinton 《Nursing economic$》1991,9(4):221-231
Medical effectiveness initiatives, outcomes research, and practice guidelines--the new buzz words for the 90s--will change the way health care services are delivered and allocated. The focal point for medical effectiveness and health services research for the federal government is the Public Health Service's newest agency, the Agency for Health Care Policy and Research. The agency is headed by J. Jarrett Clinton, MD, MPH, administrator, who also served as acting administrator since the creation of the agency in December 1989 until April 1991. In this interview, Dr. Clinton discusses the agency's responsibilities, his perspective on the agency's work, and the effect of health services research on the U.S. health care delivery system. 相似文献
8.
Bone RC 《Medical economics》1996,73(23):114-6, 119-20, 122 passim
9.
10.
Hayes AH 《Medical economics》1982,59(16):47-8, 52, 56
11.
Norwood C 《Medical economics》1998,75(2):40, 42, 45
12.
13.
Thomas B 《Medical economics》1995,72(10):146-8, 151, 154 passim
14.
Brailer DJ 《Medical economics》2004,81(16):26, 28-26, 29
15.
16.
17.
Cassel CK 《Medical economics》1997,74(10):110-2, 122-8, 133
18.
Bagley B 《Medical economics》2004,81(5):117-118
19.
20.
Bennett RF 《Medical economics》1995,72(16):137-8, 142, 144-6 passim